Features and Advantages:

An Innovative and Effective Tool for Precise Thrombosis Prevention and Treatment;

Significantly Enhancing Thrombosis Prevention and Treatment Standards Capable of screening 81.82% - 100% of individuals at high risk of thrombosis;

Enables proper guidance for the effective and safe use of antiplatelet drugs;

Adopted by over 400 Grade A tertiary hospitals nationwide (in China) as well as renowned medical institutions in Europe and America;

Applied in four national-level research projects and two international multi-center clinical trials;

To date, numerous large-scale clinical validation studies—conducted by scholars worldwide using different methods to explore the correlation between platelet function and thrombosis—have consistently confirmed that the Aggrestar (PL) Platelet Function Analyzer can effectively and accurately screen patients at high risk of thrombosis, and holds great value for the effectiveness and safety of thrombosis prevention and treatment;

Features a unique function to screen out unqualified samples, effectively avoiding erroneous results commonly caused by substandard blood sample quality.